However, with mixed bone marrow chimeric mice in which PPARγ was specifically deleted in iNKT cells, we confirmed that PPARγ expression in iNKT cells was required for the anti-tumor efficacy of PIO and αGC treatment (Fig. 7o-q). This evidence concerns the gene PPARG and neoplasm.